SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Home Bancorp, Inc. (HBCP) trades at a trailing P/E of 10.8, forward P/E of 11.1. Trailing earnings yield is 9.26%, forward earnings yield 9.05%. PEG 0.38 (Peter Lynch undervalued ≤1.0). Graham Number is $86.91.
Criteria proven by this page:
- VALUE (41/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- PEG Ratio 0.38 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 9.26% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $50.00 (-22.5% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 65/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
41/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HBCP
Valuation Multiples
P/E (TTM)10.8
Forward P/E11.1
PEG Ratio0.38
Forward PEG2.13
P/B Ratio1.14
P/S Ratio2.41
EV/EBITDA7.0
Per Share Data
EPS (TTM)$5.96
Forward EPS (Est.)$5.84
Book Value / Share$56.31
Revenue / Share$27.09
FCF / Share$5.74
Yields & Fair Value
Earnings Yield9.26%
Forward Earnings Yield9.05%
Dividend Yield1.83%
Graham Number$86.91
SharesGrow IV$143.33 (+122.1%)
Analyst Target$50.00 (-22.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
16.5 |
0.66 |
1.47 |
3.35 |
1.13% |
| 2017 |
18.3 |
2.67 |
1.11 |
3.64 |
1.32% |
| 2018 |
10.2 |
0.26 |
1.06 |
2.78 |
2.09% |
| 2019 |
12.7 |
-1.11 |
1.12 |
3.05 |
2.22% |
| 2020 |
9.8 |
-1.37 |
0.75 |
2.05 |
3.26% |
| 2021 |
7.2 |
0.07 |
0.99 |
2.82 |
2.26% |
| 2022 |
9.6 |
-0.34 |
0.99 |
2.33 |
2.39% |
| 2023 |
8.4 |
0.43 |
0.92 |
1.89 |
2.44% |
| 2024 |
10.1 |
-1.18 |
0.93 |
1.85 |
2.22% |
| 2025 |
9.8 |
0.33 |
1.03 |
2.15 |
2.00% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.25 |
$78.84M |
$16.01M |
20.3% |
| 2017 |
$2.41 |
$84.36M |
$16.82M |
19.9% |
| 2018 |
$3.40 |
$115.76M |
$31.59M |
27.3% |
| 2019 |
$3.05 |
$116.62M |
$27.93M |
24% |
| 2020 |
$2.85 |
$118.43M |
$24.77M |
20.9% |
| 2021 |
$5.77 |
$123.17M |
$48.62M |
39.5% |
| 2022 |
$4.16 |
$139.82M |
$34.07M |
24.4% |
| 2023 |
$4.99 |
$178.3M |
$40.24M |
22.6% |
| 2024 |
$4.57 |
$199.39M |
$36.43M |
18.3% |
| 2025 |
$5.87 |
$209.23M |
$46.06M |
22% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$5.83 |
$5.66 – $6.01 |
$154.93M |
$154.03M – $155.83M |
3 |
| 2027 |
$6.13 |
$6.00 – $6.34 |
$162.1M |
$160.56M – $163.64M |
3 |
